Alaa Mashabi

Alaa Mashabi

Auto-generated profile, based on publicly available information

Alaa Mashabi

School of Pharmacy, University of Nottingham Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, U.K.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
SGScott Grossman
Scott Grossman
FSFadi Soukarieh
Fadi Soukarieh
WRWilliam Richardson
William Richardson
RLRuiling Liu
Ruiling Liu
AMAlaa Mashabi
Alaa Mashabi
MSMichael Stocks
Michael Stocks
Rising numbers of cases of multidrug- and extensively drug-resistant Pseudomonas aeruginosa over recent years have created an urgent need for novel therapeutic approaches to cure potentially fatal infections. One such approach is virulence attenuation where anti-virulence compounds, designed to reduce pathogenicity without affording bactericidal effects, are employed to treat infections. P. aeruginosa uses the pqs quorum sensing (QS) system, to coordinate the expression of a large number of virulence determinants as well as bacterial-host interactions and hence represents an excellent anti-virulence target.

3 January 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
FSFadi Soukarieh
Fadi Soukarieh
AMAlaa Mashabi
Alaa Mashabi
WRWilliam Richardson
William Richardson
EOEduard Vico Oton
Eduard Vico Oton
MRManuel Romero
Manuel Romero
MCMiguel Camara
Miguel Camara
Pseudomonas aeruginosa is one of the top priority pathogens that requires immediate attention according to the World Health Organisation (WHO). Due to the alarming shortage of novel antimicrobials, targeting quorum sensing (QS), a bacterial cell to cell signaling system controlling virulence, has emerged as a promising approach as an antibiotic adjuvant therapy. Interference with the pqs system, one of three QS systems in P. aeruginosa, results in reduction of bacterial virulence gene expression and biofilm maturation. Herein, we report a hit to lead process to fine-tune the potency of our previously reported inhibitor 1 (IC50 3.2 μM in P. aeruginosa PAO1-L), which led to the discovery of 2-(4-(3-((6-chloro-1-isopropyl-1H-benzo[d]imidazol-2-yl)amino)-2-hydroxypropoxy)phenyl)acetonitrile (6f) as a potent PqsR antagonist. Compound 6f inhibited the PqsR-controlled PpqsA-lux transcriptional reporter fusion in P. aeruginosa at low submicromolar concentrations. Moreover, 6f showed improved efficacy against P. aeruginosa CF isolates with significant inhibition of pyocyanin, 2-alkyl-4(1H)-quinolones production.

17 July 2026 in IJID Regions
Verified
Journal Article
Open access
AMAlaa Mashabi
Alaa Mashabi
HAHanadi Alrammaal
Hanadi Alrammaal
NSNada Safhi
Nada Safhi
ZKZain Khayyat
Zain Khayyat